Chau Q. Khuong joined OrbiMed Advisors, LLC, in 2003 to focus on biotechnology and medical device investments in both private equity and small capitalization public companies. Mr. Khuong has experience in start-up operations and business development at Veritas Medicine, Inc. and in basic science research at the Yale School of Medicine and at Massachusetts General Hospital. He was a summer Associate in the New Ventures technology transfer group at Columbia University. Mr. Khuong holds a BS in molecular, cellular and developmental biology with a concentration in biotechnology and an MPH with a concentration in infectious disease, both from Yale University. He was actively involved in OrbiMed investments in Arius Research, Inc. (acquired by Roche in 2008), Peninsula Pharmaceuticals, Inc. (acquired by Johnson & Johnson, Inc., in 2005), Cerexa, Inc. (acquired by Forest Laboratories, Inc., in 2007), Adiana, Inc. (acquired by Cytyc Corpo ration in 2007), Biodel, Inc. (NASDAQ: BIOD) and Emphasys Medical, Inc. Mr. Khuong currently serves on the board of directors at Cerapedics, Inc., and is an observer on the board of directors at Biolex Therapeutics, Glaukos Corporation, Igenica, and Pieris AG.
Back to Top